Up Next
ki-logo-white
Market-Based Solutions to Vital Economic Issues
SEARCH
SHOW RESULTS FOR:
Everything
Resources
Video
Research
News & Media
Events
Kenan Insights
About
Our People
Our Leadership Board
Our Community
Students
Contextual Education
Dual Degree Programs
CBOH Career Networks
Opioid Settlement Playbook
Research & Insights
Events & Programs
News & Media
CBOH Spotlights
Make a Gift
Contact Us
A PARTNER OF THE
KENAN INSTITUTE OF PRIVATE ENTERPRISE
AND
THE UNC KENAN-FLAGLER BUSINESS SCHOOL
ki-logo-black
Resources
Jul 15, 2022
Pfizer's Xalkori picks up FDA nod for rare ALK-positive tumors
EXPLORE
MORE CONTENT
Keyword(s):
Pharmaceuticals and Life Sciences
39
Learn more at:
https://cboh.kenaninstitute.unc.edu/resources/pfizers-xalkori-picks-up-fda-nod-for-rare-alk-positive-tumors/
You may also be interested in:
